Israeli/U.S.-based biotech company Ukko is taking a revolutionary approach to the distressing problem of food allergies and gluten sensitivities: their scientists are designing and engineering proteins that keep the good biophysical properties of the original proteins, while removing the immune-triggering parts that can cause life-threatening allergies. The end goal is proteins that are safe for everyone. Ukko is focusing first on developing a new safe gluten protein for use in baking and a new peanut protein for use as a therapeutic. Their unique platform could theoretically be used for any protein-based allergy, including cats and bees. Hear more in this episode, featuring Ukko CEO Anat Binur.
Podden och tillhörande omslagsbild på den här sidan tillhör Matt Fuchs. Innehållet i podden är skapat av Matt Fuchs och inte av, eller tillsammans med, Poddtoppen.